Company news

Spero Therapeutics, Inc. news in 2019

Spero Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.

View company

Spero Reports Preliminary Findings from Phase 1 Clinical Trial of SPR720 and Announces Plans to Advance Program into Proof-of-Concept Clinical Trial in Patients with NTM Pulmonary Disease

December 3, 2019

Spero Therapeutics to Host Key Opinion Leader Symposium in December

November 25, 2019

Spero Therapeutics Announces Third Quarter 2019 Operating Results and Provides Pipeline Review

November 3, 2019

Spero Therapeutics Announces Positive Recommendation to Continue Phase 3 Clinical Trial of SPR994 as Planned Following Independent Review Committee Analysis of SPR994 Treated Patients in Lead-in Cohort of Trial

October 2, 2019

Spero Therapeutics Announces Presentations at IDWeek 2019

September 25, 2019

Decks in 2019